Rep. Matt Gaetz (R-FL) is President-elect Donald Trump’s choice to serve as the next U.S. attorney general—a selection that ...
President-elect Donald Trump has named Robert F. Kennedy Jr. as his pick to lead the U.S. Department of Health and Human ...
A new study led by the one of the only people permitted by the U.S. government to grow marijuana for research purposes finds ...
Only hours after embattled former Rep. Matt Gaetz (R-FL) withdrew his name from consideration for attorney general, President-elect Donald Trump announced that former Florida Attorney General Pam ...
“This attempt to flood the zone and place their thumb on the scale at the expense of legitimate social equity applicants is disturbing.” The nascent Office of Cannabis Management (OCM) unlawfully ...
Senate Majority Leader Chuck Schumer (D-NY) remains committed to moving a bipartisan marijuana banking bill during the lame duck session, a senior staffer says—while also confirming that the senator ...
A new study of more than 5,000 men whom researchers evaluated over the course of 44 years found “no significant harmful effects of cannabis use on age-related cognitive decline.” In fact, the report ...
A Drug Enforcement Administration (DEA) judge is giving the agency less than a week to respond to recent allegations that it illegally communicated with the prohibitionist group Smart Approaches to ...
A study committee in Georgia’s Senate is recommending that the state earmark as much as $5 million to fund research into how psychedelic substances such as MDMA and psilocybin might be used to treat ...
A coalition of 67 Democratic members of Congress are calling on President Joe Biden to expand on his executive clemency work in the final months of his term, citing his past marijuana pardons as an ...
In what appears to be a first for public workers in the U.S., medical marijuana coverage is being added as a healthcare benefit for employees in three New Jersey municipalities, providing access to ...
A Drug Enforcement Administration (DEA) judge has denied a request from a drug development company to participate in an upcoming marijuana rescheduling hearing, deferring to the head of the agency ...